Skip to content

Clinical trials

Expanded access trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Expanded access Country / region: Japan Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

No trials to chart.

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
No longer available7
Approved for marketing4
Available2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
U.S. Army Medical Research and Development Command2
Amgen1
Astellas Pharma Global Development, Inc.1
AstraZeneca1
Bayer1
BioMarin Pharmaceutical1
Bristol-Myers Squibb1
Eli Lilly and Company1
Janssen Research & Development, LLC1
Kite, A Gilead Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung2
Multiple Myeloma2
Bites and Stings1
Breast Neoplasms1
COVID-191
Carcinoma, Medullary1
Colonic Neoplasms1
Hypertension, Pulmonary1
Leukemia, Myeloid, Acute1
Lung Neoplasms1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.